Rehm, H. L. et al. ClinGen — the clinical genome resource. N. Engl. J. Med. 372, 2235–2242 (2015).PubMed
PubMed Central
Google Scholar
Sollis, E. et al. The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, D977–D985 (2023).PubMed
Google Scholar
Ochoa, D. et al. The next-generation open targets platform: reimagined, redesigned, rebuilt. Nucleic Acids Res. 51, D1353–D1359 (2023).PubMed
Google Scholar
Tian, R. et al. Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis. Nat. Neurosci. 24, 1020–1034 (2021).PubMed
PubMed Central
Google Scholar
Ghoussaini, M. et al. Open targets genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 49, D1311–D1320 (2021).PubMed
Google Scholar
Dhindsa, R. S. et al. Rare variant associations with plasma protein levels in the UK Biobank. Nature 622, 339–347 (2023).PubMed
PubMed Central
Google Scholar
Karczewski, K. J. et al. Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes. Cell Genomics 2, 100168 (2022).PubMed
PubMed Central
Google Scholar
The Europe PMC Consortium. Europe PMC: a full-text literature database for the life sciences and platform for innovation. Nucleic Acids Res. 43, D1042–D1048 (2015).
Google Scholar
Kafkas, Ş., Dunham, I. & McEntyre, J. Literature evidence in open targets – a target validation platform. J. Biomed. Semant. 8, 20 (2017).
Google Scholar
Piñero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45, D833–D839 (2017).PubMed
Google Scholar
Li, G. et al. miRTex: a text mining system for miRNA-gene relation extraction. PLOS Comput. Biol. 11, e1004391 (2015).PubMed
PubMed Central
Google Scholar
Chen, J. et al. RNADisease v4.0: an updated resource of RNA-associated diseases, providing RNA-disease analysis, enrichment and prediction. Nucleic Acids Res. 51, D1397–D1404 (2023).PubMed
Google Scholar
Li, Q., Kim, S., Zaslavsky, L., Cheng, T. & Yu, B. Resource description framework (RDF) modeling of named entity co-occurrences derived from biomedical literature in the PubChemRDF https://ceur-ws.org/Vol-3415/paper-4.pdf (2023).Esaki, T. & Ikeda, K. Difficulties and prospects of data curation for ADME in silico modeling. CBIJ 23, 1–6 (2023).
Google Scholar
Suzuki, T., Ono, Y. & Bono, H. Comparison of oxidative and hypoxic stress responsive genes from meta-analysis of public transcriptomes. Biomedicines 9, 1830 (2021).PubMed
PubMed Central
Google Scholar
Bono, H. Meta-analysis of oxidative transcriptomes in insects. Antioxidants 10, 345 (2021).PubMed
PubMed Central
Google Scholar
Dorsey, E. R. et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 17, 939–953 (2018).
Google Scholar
Davie, C. A. A review of Parkinson’s disease. Br. Med. Bull. 86, 109–127 (2008).PubMed
Google Scholar
Obeso, J. A. et al. Missing pieces in the Parkinson’s disease puzzle. Nat. Med 16, 653–661 (2010).PubMed
Google Scholar
Wiecki, T. V. & Frank, M. J. Chapter 14 – Neurocomputational models of motor and cognitive deficits in Parkinson’s disease. In: Progress in Brain Research (eds. Björklund, A. & Cenci, M. A.) vol. 183, 275–297 (Elsevier, 2010).Sahoo, S., Padhy, A. A., Kumari, V. & Mishra, P. Role of ubiquitin–proteasome and autophagy-lysosome pathways in α-synuclein aggregate clearance. Mol. Neurobiol. 59, 5379–5407 (2022).PubMed
Google Scholar
Zhou, Z. D., Yi, L. X., Wang, D. Q., Lim, T. M. & Tan, E. K. Role of dopamine in the pathophysiology of Parkinson’s disease. Transl. Neurodegener. 12, 44 (2023).PubMed
PubMed Central
Google Scholar
Ramesh, S., Arachchige, A. S. P. M., Ramesh, S. & Arachchige, A. S. P. M. Depletion of dopamine in Parkinson’s disease and relevant therapeutic options: a review of the literature. AIMSN 10, 200–231 (2023).
Google Scholar
Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson’s disease. J. Parkinson’s Dis. 3, 461–491 (2013).
Google Scholar
Klinkovskij, A., Shepelev, M., Isaakyan, Y., Aniskin, D. & Ulasov, I. Advances of genome editing with CRISPR/Cas9 in neurodegeneration: the right path towards therapy. Biomedicines 11, 3333 (2023).PubMed
PubMed Central
Google Scholar
Simmnacher, K. et al. Unique signatures of stress-induced senescent human astrocytes. Exp. Neurol. 334, 113466 (2020).PubMed
Google Scholar
Krauskopf, J. et al. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson’s disease. Mol. Psychiatry 27, 4355–4367 (2022).PubMed
Google Scholar
Tong, Z.-B., Braisted, J., Chu, P.-H. & Gerhold, D. The MT1G Gene in LUHMES neurons is a sensitive biomarker of neurotoxicity. Neurotox. Res. 38, 967–978 (2020).PubMed
PubMed Central
Google Scholar
The irradiated brain microenvironment supports glioma stemness and survival via astrocyte-derived transglutaminase 2 | Cancer Research | American Association for Cancer Research. https://aacrjournals.org/cancerres/article/81/8/2101/670586/The-Irradiated-Brain-Microenvironment-Supports (2021).Shimada, M., Tsukada, K., Kagawa, N. & Matsumoto, Y. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells. J. Radiat. Res. 60, 719–728 (2019).PubMed
PubMed Central
Google Scholar
Loeliger, B. W. et al. Effect of ionizing radiation on transcriptome during neural differentiation of human embryonic stem cells. Rare 193, 460–470 (2020).
Google Scholar
Murotomi, K. et al. Cyclo-glycylproline attenuates hydrogen peroxide-induced cellular damage mediated by the MDM2-p53 pathway in human neural stem cells. J. Cell. Physiol. 238, 434–446 (2023).PubMed
Google Scholar
Crowe, E. P. et al. Changes in the transcriptome of human astrocytes accompanying oxidative stress-induced senescence. Front. Aging Neurosci. 8, 208 (2016).Suzuki, T. A systematic exploration of unexploited disease-related genes. https://doi.org/10.6084/m9.figshare.c.7114075.v2 (2024).Barrett, T. et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 41, D991–D995 (2013).PubMed
Google Scholar
Mariani, E. et al. Meta-analysis of Parkinson’s disease transcriptome data using TRAM software: whole substantia nigra tissue and single dopamine neuron differential gene expression. PLoS One 11, e0161567 (2016).PubMed
PubMed Central
Google Scholar
Phung, D. M. et al. Meta-analysis of differentially expressed genes in the substantia nigra in Parkinson’s disease supports phenotype-specific transcriptome changes. Front. Neurosci. 14, (2020).Cappelletti, C. et al. Transcriptomic profiling of Parkinson’s disease brains reveals disease stage specific gene expression changes. Acta Neuropathol. 146, 227–244 (2023).PubMed
PubMed Central
Google Scholar
Lu, M. et al. TWAS Atlas: a curated knowledgebase of transcriptome-wide association studies. Nucleic Acids Res. 51, D1179–D1187 (2023).PubMed
Google Scholar
szktkyk. szktkyk/gene-disease-linker (2024).Index of /gene/DATA. https://ftp.ncbi.nlm.nih.gov/gene/DATA/.Kia, D. A. et al. Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol. 78, 464–472 (2021).PubMed
Google Scholar
Li, Y. I., Wong, G., Humphrey, J. & Raj, T. Prioritizing Parkinson’s disease genes using population-scale transcriptomic data. Nat. Commun. 10, 994 (2019).PubMed
PubMed Central
Google Scholar
Chen, L. et al. Study of molecular patterns associated with ferroptosis in Parkinson’s disease and its immune signature. PLoS One 18, e0295699 (2023).PubMed
PubMed Central
Google Scholar
Chung, S.-K. & Lee, S.-Y. Advances in gene therapy techniques to treat LRRK2 gene mutation. Biomolecules 12, 1814 (2022).PubMed
PubMed Central
Google Scholar
Lei, J., Aimaier, G., Aisha, Z., Zhang, Y. & Ma, J. eEF1A1 regulates the expression and alternative splicing of genes associated with Parkinson’s disease in U251 cells. Genes Genom. 46, 817–829 (2024).Zhang, X., Hu, D., Shang, Y. & Qi, X. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165431 (2020).PubMed
Google Scholar
Liu, J. et al. NUPR1 is a critical repressor of ferroptosis. Nat. Commun. 12, 647 (2021).PubMed
PubMed Central
Google Scholar
Wang, X. et al. UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation. Development 149, dev195644 (2022).PubMed
PubMed Central
Google Scholar
Bucher, M. L. et al. Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease. npj Parkinsons Dis. 6, 1–13 (2020).
Google Scholar
Choi, W.-S., Kim, H.-W. & Xia, Z. JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death. Toxicology 328, 75–81 (2015).PubMed
Google Scholar
Su, C.-J. et al. Thioredoxin-interacting protein induced α-synuclein accumulation via inhibition of autophagic flux: Implications for Parkinson’s disease. CNS Neurosci. Ther. 23, 717–723 (2017).PubMed
PubMed Central
Google Scholar
Yang, D. et al. Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease. npj Parkinsons Dis. 9, 1–6 (2023).
Google Scholar
Gong, L. et al. Neurofilament light chain (NF-L) stimulates lipid peroxidation to neuronal membrane through microglia-derived ferritin heavy chain (FTH) secretion. Oxid. Med. Cell. Longev. 2022, e3938940 (2022).
Google Scholar
Gellhaar, S., Sunnemark, D., Eriksson, H., Olson, L. & Galter, D. Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson’s and Alzheimer’s disease. Cell Tissue Res. 369, 445–454 (2017).PubMed
PubMed Central
Google Scholar
Maki, R. A. et al. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson’s disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment. Free Radic. Biol. Med. 141, 115–140 (2019).PubMed
PubMed Central
Google Scholar
Verdiperstat | ALZFORUM https://www.alzforum.org/therapeutics/verdiperstat.Chang, C. Y., Choi, D.-K., Lee, D. K., Hong, Y. J. & Park, E. J. Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells. PLoS One 8, e60654 (2013).PubMed
PubMed Central
Google Scholar
Zhao, J. et al. LINC00938 alleviates hypoxia ischemia encephalopathy induced neonatal brain injury by regulating oxidative stress and inhibiting JNK/p38 MAPK signaling pathway. Exp. Neurol. 367, 114449 (2023).PubMed
Google Scholar
Yousefi, M., Peymani, M., Ghaedi, K., Irani, S. & Etemadifar, M. Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease. Sci. Rep. 12, 2569 (2022).PubMed
PubMed Central
Google Scholar
Liu, C., Fang, J. & Liu, W. Superoxide dismutase coding of gene polymorphisms associated with susceptibility to Parkinson’s disease. J. Integr. Neurosci. 18, 299–303 (2019).PubMed
Google Scholar
Yu, H. et al. yyoshiaki/ikra: ikra v2.0.1. Zenodo https://doi.org/10.5281/zenodo.5541399 (2021).The NCBI SRA (Sequence Read Archive); NCBI—National Center for Biotechnology Information/NLM/NIH: Bethesda, MD, USA, 2021.Babraham Bioinformatics – Trim Galore! https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/.Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017).PubMed
PubMed Central
Google Scholar
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).PubMed
PubMed Central
Google Scholar